Shots:
- Xcell Biosciences entered into a strategic collaboration with ThermoFisher Scientific to advance the development of Treg and TIL cell therapies for autoimmune and solid tumor treatments
- The joint research aims to develop methodologies for enhancing the efficacy of Tregs and TILs, while streamlining and scaling cell therapy manufacturing for improved accessibility and reproducibility across global pt populations
- Xcellbio will leverage its AVATAR cell therapy manufacturing platform, in collaboration with ThermoFisher, to develop Treg and TIL cell therapy treatments for the pts
Ref: Bussinesswire| Image: Xcell Biosciences and ThermoFisher| Press Release
Related News:- Harbour BioMed Enters a ~$670M Partnership with Otsuka Pharmaceutical to Advance HBM7020 for Autoimmune Diseases
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
